UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 10 – Q/A
(Amendment No.1)
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2018
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________ to ___________
Commission File Number
0-51481
STRATA SKIN SCIENCES, INC.
(Exact name of registrant as specified in its charter)
|
|
Delaware
(State or other jurisdiction
of incorporation or organization)
|
|
13-3986004
(I.R.S. Employer
Identification No.)
|
|
100 Lakeside Drive, Suite 100, Horsham, Pennsylvania 19044
(Address of principal executive offices, including zip code)
(215) 619-3200
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant: (i) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (ii) has been subject to such filing requirements for the past 90 days.
Yes
ý
No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
ý
No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
|
Large accelerated filer ☐
|
|
Accelerated filer ☐
|
|
|
|
Non-accelerated filer ☐
|
|
Smaller reporting company
ý
|
|
|
|
Emerging growth company ☐
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes ☐ No
ý
The number of shares outstanding of the issuer's common stock as of November 13, 2018 was 29,943,086 shares.
Explanatory Note
This Amendment No. 1 to the Quarterly Report on Form 10-Q of STRATA Skin Sciences, Inc. (the "Company") for the quarter ended September 30, 2018, originally filed on November 14, 2018 (the "Original Filing"), is being filed solely to include the XBRL documents as Exhibit 101, which were inadvertently omitted from the Original Filing as originally filed due to technical difficulties.
Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended, this Form 10-Q/A also contains new certifications pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, which are attached hereto.
Except as described above, no other changes have been made to the Original Filing, and this Form 10-Q/A does not modify, amend or update in any way any of the financial or other information contained in the Original Filing. This Form 10-Q/A does not reflect events that may have occurred subsequent to the filing date of the Original Filing.
EXHIBIT INDEX
The following is a list of all exhibits filed as a part of this Quarterly Report on Form 10-Q/A.
|
31.1
|
|
|
|
31.2
|
|
|
|
32.1*
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Schema
|
|
101.CAL
|
|
XBRL Taxonomy Calculation Linkbase
|
|
101.DEF
|
|
XBRL Taxonomy Definition Linkbase
|
|
101.LAB
|
|
XBRL Taxonomy Label Linkbase
|
|
101.PRE
|
|
XBRL Taxonomy Presentation Linkbase
|
|
*
|
The certifications attached as Exhibit 32.1 accompany this Quarterly Report on Form 10-Q/A pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed "filed" by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
STRATA SKIN SCIENCES, INC
.
|
|
|
Date November 14, 2018
|
By:
|
/s/ Dolev Rafaeli
|
|
|
|
|
Name Dolev Rafaeli
|
|
|
|
|
Title President & Chief Executive Officer
|
|
|
Date November 14, 2018
|
By:
|
/s/ Matthew C. Hill
|
|
|
|
|
Name Matthew C. Hill
|
|
|
|
|
Title Chief Financial Officer
|
|